Related references
Note: Only part of the references are listed.Attenuation of type-1 diabetes-induced cardiovascular dysfunctions by direct thrombin inhibitor in rats: a mechanistic study
Yogesh Bulani et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Cardiac fibroblast activation and hyaluronan synthesis in response to hyperglycemia and diet-induced insulin resistance
Daniel J. Gorski et al.
SCIENTIFIC REPORTS (2019)
Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation
Xuelian Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
Masafumi Takahashi
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
Coriolus versicolor alleviates diabetic cardiomyopathy by inhibiting cardiac fibrosis and NLRP3 inflammasome activation
Yueqiu Wang et al.
PHYTOTHERAPY RESEARCH (2019)
Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction
Jingyi Liu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Role of inflammatory signaling in atrial fibrillation
Larry Scott et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
Adam J. Wilson et al.
HEART (2018)
PAR4 (Protease-Activated Receptor 4) PARticularly Important 4 Antiplatelet Therapy
Xu Han et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Chunxia Yao et al.
CIRCULATION (2018)
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Jianlin Qiao et al.
HAEMATOLOGICA (2018)
Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose PAR-4 in cardiac fibroblasts
Sonja Kleeschulte et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects
Paola Altieri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Luis E. Pavillard et al.
PHARMACOLOGICAL RESEARCH (2018)
Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress
Zhaohui Pei et al.
TOXICOLOGY LETTERS (2018)
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Jianlin Qiao et al.
HAEMATOLOGICA (2018)
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Arpeeta Sharma et al.
FRONTIERS IN PHYSIOLOGY (2018)
PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
Simon J. Wilson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
Gong Chen et al.
FRONTIERS IN PHYSIOLOGY (2018)
Platelet activity and hypercoagulation in type 2 diabetes
Lesha Pretorius et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Spotlight on the NLRP3 inflammasome pathway
Marine Groslambert et al.
JOURNAL OF INFLAMMATION RESEARCH (2018)
Tissue factor levels in type 2 diabetes mellitus
Prashilla Soma et al.
INFLAMMATION RESEARCH (2017)
Thrombin promotes diet-induced obesity through fibrin-driven inflammation
Anna K. Kopec et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Alyssa Faria et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
Pancras C. Wong et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
Anke C. Fender et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging
Jeremy Lagrange et al.
FRONTIERS IN PHYSIOLOGY (2017)
Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression
Yogesh Bulani et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
ROS/TXNIP pathway contributes to thrombin induced NLRP3 inflammasome activation and cell apoptosis in microglia
Xinchun Ye et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Actions of thrombin in the interstitium
G. G. de Ridder et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Association of weight gain with coronary artery disease, inflammation and thrombogenicity
Rahul Chaudhary et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
Caroline Pereira Domingueti et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
Shauna L. French et al.
PLOS ONE (2016)
Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
Koichiro Mihara et al.
MOLECULAR PHARMACOLOGY (2016)
Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy
Lifang Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events
Elena Campello et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
Beibei Luo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Thrombin Receptor Protease-Activated Receptor 4 Is a Key Regulator of Exaggerated Intimal Thickening in Diabetes Mellitus
Goran Pavic et al.
CIRCULATION (2014)
Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice
Lindisley F. Gomides et al.
INFLAMMATION RESEARCH (2014)
Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes
Shailaja Mahajan-Thakur et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Beibei Luo et al.
PLOS ONE (2014)
Thrombin Inhibition with Dabigatran Protects against High-Fat Diet-Induced Fatty Liver Disease in Mice
Anna K. Kopec et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts
Dmitry L. Sonin et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human Atria
Keiichi Ito et al.
PLOS ONE (2013)
Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation
Florian Prueller et al.
ATHEROSCLEROSIS (2012)
Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts
Aaron N. Snead et al.
FASEB JOURNAL (2012)
Inflammatory and Prothrombotic States in Obese Children of European Descent
Sophie Stoppa-Vaucher et al.
OBESITY (2012)
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation - The Hoorn Study
Hanneke J. B. H. Beijers et al.
THROMBOSIS RESEARCH (2012)
High Glucose Enhances Thrombin Responses via Protease-Activated Receptor-4 in Human Vascular Smooth Muscle Cells
Seema Dangwal et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents
Paola Giordano et al.
EUROPEAN JOURNAL OF PEDIATRICS (2011)
Differential Expression of NLRP3 among Hematopoietic Cells
Greta Guarda et al.
JOURNAL OF IMMUNOLOGY (2011)
Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair?
Darrell H. Carney et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
TP508 (Chrysalin®) reverses endothelial dysfunction and increases perfusion and myocardial function in hearts with chronic ischemia
Theresa W. Fossum et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy
Rafal Pawlinski et al.
CIRCULATION (2007)
Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy
Dirk Westermann et al.
DIABETES (2007)
Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury
Subrina Jesmin et al.
INFLAMMATION (2007)
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure
N Hanna et al.
CARDIOVASCULAR RESEARCH (2004)
Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism
A Sabri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women
M Romano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Tissue factor deficiency cause's cardiac fibrosis and left ventricular dysfunction
R Pawlinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)